Goldman Sachs predicts FDA will approve coronavirus vaccine this year
"While highly uncertain, our baseline expectation is that a large number of vaccines eventually gain approval with at least one FDA approval this year," Daan Struyven, a senior economist at Goldman, told investors in a report
